Pyrogen Testing Market Growth, Size, Trends Analysis - By Product, By Test Type, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Description

Pyrogen Testing Market Introduction and Overview

According to SPER market research, 'Global Pyrogen Testing Market Size- By Product, By Test Type, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Pyrogen Testing Market is predicted to reach 4.18 billion by 2034 with a CAGR of 11.41%.

Pyrogen testing is an important practice in the healthcare industry that ensures the safety and efficacy of medical devices and medications. Pyrogens are compounds that cause fevers and can be found in injectable drugs, medical equipment, and other products. They are frequently microbial toxins, such as endotoxins produced by gram-negative bacteria, that can induce severe reactions if introduced into the human body. Pyrogen tests are used to detect and quantify contaminants.

Restraints: The increasing complexity of technology significantly limits the pyrogen testing market by raising the barriers to adoption and operational efficiency. Recombinant Factor C (rFC) assay and Limulus Amebocyte Lysate (LAL) assay are examples of advanced techniques that require specialised equipment and highly skilled personnel to perform accurately.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Product, By Test Type, By End-User

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered Charles River Laboratories, Ellab A/S, Merck KGaA, GenScript, bioMA(C)rieux SA, Lonza, Thermo Fisher Scientific, Inc, Associates of Cape Cod, Inc, FUJIFILM Wako Chemicals U.S.A. Corporation (Pyrostar), MiCAN Technologies Inc.

Global Pyrogen Testing Market Segmentation:

By Product: Based on the Product, Global Pyrogen Testing Market is segmented as; Instruments, Consumables, Services.

By Test Type: Based on the Test Type, Global Pyrogen Testing Market is segmented as; LAL Test, In Vitro Pyrogen Test, Rabbit Test.

By End User: Based on the End User, Global Pyrogen Testing Market is segmented as; Pharmaceutical and biotechnology companies, Medical devices companies, Others.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Product Code: HLCA25123

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1.Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Pyrogen Testing Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Pyrogen Testing Market

7. Global Pyrogen Testing Market, By Product (USD Million) 2021-2034

7.1. Consumables
7.2. Instruments
7.3. Services

8. Global Pyrogen Testing Market, By Test Type (USD Million) 2021-2034

8.1. LAL test
- 8.1.1. Chromogenic test
- 8.1.2. Turbidimetric test
- 8.1.3. Gel clot test
8.2. In vitro pyrogen test
- 8.2.1. Recombinant Factor C (rFC) testing
- 8.2.2. Monocyte Activation Test (MAT)
8.3. Rabbit test

9. Global Pyrogen Testing Market, By End-User (USD Million) 2021-2034

9.1. Pharmaceutical and biotechnology companies
9.2. Medical devices companies
9.3. Others

10. Global Pyrogen Testing Market, (USD Million) 2021-2034

10.1. Global Pyrogen Testing Market Size and Market Share

11. Global Pyrogen Testing Market, By Region, (USD Million) 2021-2034

11.1. Asia-Pacific
- 11.1.1. Australia
- 11.1.2. China
- 11.1.3. India
- 11.1.4. Japan
- 11.1.5. South Korea
- 11.1.6. Rest of Asia-Pacific
11.2. Europe
- 11.2.1. France
- 11.2.2. Germany
- 11.2.3. Italy
- 11.2.4. Spain
- 11.2.5. United Kingdom
- 11.2.6. Rest of Europe
11.3. Middle East and Africa
- 11.3.1. Kingdom of Saudi Arabia
- 11.3.2. United Arab Emirates
- 11.3.3. Qatar
- 11.3.4. South Africa
- 11.3.5. Egypt
- 11.3.6. Morocco
- 11.3.7. Nigeria
- 11.3.8. Rest of Middle-East and Africa
11.4. North America
- 11.4.1.Canada
- 11.4.2. Mexico
- 11.4.3. United St ates
11.5. Latin America
- 11.5.1. Argentina
- 11.5.2. Brazil
- 11.5.3. Rest of Latin America

12. Company Profile

12.1. Charles River Laboratories
- 12.1.1. Company details
- 12.1.2. Financial outlook
- 12.1.3. Product summary
- 12.1.4. Recent developments
12.2. Novo Nordisk
- 12.2.1. Company details
- 12.2.2. Financial outlook
- 12.2.3. Product summary
- 12.2.4. Recent developments
12.3. Merck KGaA
- 12.3.1. Company details
- 12.3.2. Financial outlook
- 12.3.3. Product summary
- 12.3.4. Recent developments
12.4. GenScript
- 12.4.1. Company details
- 12.4.2. Financial outlook
- 12.4.3. Product summary
- 12.4.4. Recent developments
12.5. bioMA(C)rieux SA
- 12.5.1. Company details
- 12.5.2. Financial outlook
- 12.5.3. Product summary
- 12.5.4. Recent developments
12.6. Lonza Group
- 12.6.1. Company details
- 12.6.2. Financial outlook
- 12.6.3. Product summary
- 12.6.4. Recent developments
12.7. Thermo Fisher Scientific, Inc
- 12.7.1. Company details
- 12.7.2. Financial outlook
- 12.7.3. Product summary
- 12.7.4. Recent developments
12.8. Seikagaku Biobusiness Corporation
- 12.8.1. Company details
- 12.8.2. Financial outlook
- 12.8.3. Product summary
- 12.8.4. Recent developments
12.9. FUJIFILM Wako Chemicals U.S.A. Corporation (Pyrostar)
- 12.9.1. Company details
- 12.9.2. Financial outlook
- 12.9.3. Product summary
- 12.9.4. Recent developments
12.10. MiCAN Technologies Inc
- 12.10.1. Company details
- 12.10.2. Financial outlook
- 12.10.3. Product summary
- 12.10.4. Recent developments
12.11. Others